What serious adverse reactions happened during this study?
The most common serious adverse reaction was anemia.
The table below shows the serious adverse reactions that happened in more than
1 participant during the study. There were other serious adverse reactions, but
these happened in fewer participants.
Most common serious adverse reactions
Olaparib NHA treatments
Serious adverse reaction (out of 256 participants) (out of 130 participants)
Anemia 6.3% (16) 0.0% (0)
Decreased numbers of a type
of white blood cell called 1.2% (3) 0.0% (0)
neutrophils
Decreased numbers of blood
cells that help form blood 1.2% (3) 0.0% (0)
clots
Vomiting 1.2% (3) 0.0% (0)
Lung infection 0.8% (2) 0.0% (0)
Blood clot in the lungs 0.8% (2) 0.0% (0)
General weakness 0.4% (1) 0.8% (1)
There were 0.5% of participants who died because of serious adverse reactions.
This was 2 out of 386 participants.
> 0.4% of participants who took olaparib died because of serious adverse
reactions. This was 1 out of 256 participants.
> 0.8% of participants who took 1 of the NHA treatments died because of
serious adverse reactions. This was 1 out of 130 participants.
> Both of these deaths were because of lung problems.
13 | Clinical Study Results